Search clinical trials for: NSAA

Total 37 results

Peking Union Medical College Hospital

Recruiting

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

Aplastic Anemia | Drug Therapy | CSA

China
Red Nucleus Enterprise Solutions, LLC

Recruiting

NSAA NON-Interventional Study Protocol

Duchenne Muscular Dystrophy

United States
Nordlandssykehuset HF
University Hospital of North Norway; UiT The Arctic University of Norway; Helgelandssykehuset... and other collaborators

Active, not recruiting

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study (NSAC)

Depression | Pain | Fatigue | Anxiety Disorders | Occupational Exposure | Musculoskeletal Disorder | Work Related Stress | Return to Work | Employment | Workplace Bullying | Sickness Absence

Norway
Baio Enterprises
Baio Institute

Active, not recruiting

Neuro Strengths-Based Approach to Autism (NSBAA)

Autism Spectrum Disorder

United States
Nordlandssykehuset HF
University Hospital of North Norway; UiT The Arctic University of Norway; Helsepartner... and other collaborators

Recruiting

A Naturalistic Trial of the Norwegian Sickness Absence Clinic. The NSAC Efficacy Study (NSAC)

Depression | Pain | Fatigue | Anxiety Disorders | Occupational Exposure | Musculoskeletal Disorder | Work Related Stress | Return to Work | Employment | Workplace Bullying | Sickness Absence

Norway
University of Sydney
Canadian Cancer Trials Group; Australian and New Zealand Urogenital and Prostate... and other collaborators

Active, not recruiting

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET)

Prostatic Neoplasms

New Zealand, Canada, United States, Australia, United Kingdom, Ireland
VA Eastern Colorado Health Care System
University of Colorado, Denver

Completed

Strength and Awareness in Action: an Intervention for Post-Acute TBI Headaches (SAA-TBI) (SAA-TBI)

Traumatic Brain Injury | Post-concussive Headaches

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Multiple Dose Study Evaluating the Safety and Tolerability of NSA-789

Alzheimer Disease | Healthy Subjects

United States
Neurotronic, Inc.
Libra Medical

Completed

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR)

Type 2 Diabetes Mellitus With Circulatory Complciation

Paraguay
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

Schizophrenia

United States, France
University of Limerick
Marigot Ltd.; Enterprise Ireland

Completed

The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise

Exercise | Dietary Supplements | Metabolism

Ireland
University of Oslo
Charles University, Czech Republic; University of Oxford; Maastricht University

Completed

Sulfur Amino Acids, Energy Metabolism and Obesity (STAY)

Overweight and Obesity

Norway
Wyeth is now a wholly owned subsidiary of Pfizer

Withdrawn

Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder

Schizophrenia

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Tolerability of NSA-789

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects

Healthy
The First Affiliated Hospital with Nanjing Medical...
Zhejiang Cancer Hospital

Recruiting

Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer

Advanced Breast Cancer

China
University of North Carolina, Chapel Hill

Completed

Comparing and Interactive Concussion Education Platform to Current Education Standards

Concussion, Brain

United States
University of Sydney
National Health and Medical Research Council, Australia; European Organisation... and other collaborators

Active, not recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer (ENZARAD)

Prostatic Neoplasms

United States, Australia, United Kingdom, Spain, New Zealand, Ireland, Austria, Belgium, Slovenia
London School of Hygiene and Tropical Medicine

Completed

Evaluation of Anti-inflammatories in the Reduction of Bite Reactions

Mosquito Bite

United Kingdom
Lisa Tannock
VA Office of Research and Development

Completed

The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk

Cardiovascular Disease

United States
Institut de Myologie, France
Aparito Ltd.

Recruiting

Feasibility, Validation and Application of Digital Tools for the Follow-up of Neuromuscular Patient Mobility in Daily Living (DT4RD)

Neuromuscular Diseases

France, United Kingdom
Kanuni Sultan Suleyman Training and Research Hospital

Completed

GDM Patients and Serum Amyloid A and Interleukin-1 (IL-1) Receptor Antagonist

Gestational Diabetes

Turkey
Radboud University Medical Center

Not yet recruiting

Soft Mist Nasal Administration Device for Topical Anaesthesia of the Nasal Cavity

Anesthesia, Local

Netherlands
Beni-Suef University

Completed

Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4

Hepatitis C Virus Infection
Eli Lilly and Company

Withdrawn

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer (proMONARCH)

Metastatic Breast Cancer

United States, Taiwan, Italy, Austria, Germany, Puerto Rico, Belgium, Argentina, Brazil
Eli Lilly and Company

Completed

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

India
Bristol-Myers Squibb

Completed

Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C

Hepatitis C

France, United Kingdom, Spain, United States, Italy, Puerto Rico, Greece
Beni-Suef University

Completed

Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients

Chronic Hepatitis C Virus Infection

Egypt
University of Colorado, Denver
National Cancer Institute (NCI)

Completed

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Brain and Central Nervous System Tumors

United States
Batman Training and Research Hospital

Completed

The Effect of Turmeric on New Onset Primary Dysmenorrhea

Primary Dysmenorrhea

Turkey
Novartis Pharmaceuticals

Active, not recruiting

Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.

Breast Cancer

China
University Hospital, Toulouse

Recruiting

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Cerebrovascular Accident

France
Nanhua University
Buddhist Tzu Chi General Hospital; Solano Semiconductor Technology., LTD.

Completed

Effect of Health Promotion on Allergic Rhinitis by Infrared-C Ray Irradiation

Allergic Rhinitis
Bristol-Myers Squibb

Completed

Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin (D-LITE)

Hepatitis C

France, Germany, Italy, Japan, United States, Australia, Puerto Rico, Spain, New Zealand
University of Monastir

Completed

IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic (NSAIvsNM)

Renal Colic

Tunisia
Borstkanker Onderzoek Groep

Active, not recruiting

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Breast Neoplasm Female

Netherlands
Novartis Pharmaceuticals

Completed

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer (RIGHT Choice)

Breast Cancer

India, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore

Search clinical trials for: NSAA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations